Prothipendyl has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl. |
| Hydrocodone | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl. |
| Magnesium sulfate | The therapeutic efficacy of Prothipendyl can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Prothipendyl may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl. |
| Mirtazapine | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl. |
| Orphenadrine | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl. |
| Pramipexole | Prothipendyl may increase the sedative activities of Pramipexole. |
| Ropinirole | Prothipendyl may increase the sedative activities of Ropinirole. |
| Rotigotine | Prothipendyl may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Prothipendyl. |
| Sodium oxybate | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl. |
| Thalidomide | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Amisulpride | Prothipendyl may increase the antipsychotic activities of Amisulpride. |
| Methylphenidate | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Methylphenidate. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Dexmethylphenidate. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Prothipendyl. |
| Quinagolide | The therapeutic efficacy of Quinagolide can be decreased when used in combination with Prothipendyl. |
| Sulpiride | Prothipendyl may increase the antipsychotic activities of Sulpiride. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Prothipendyl. |
| Lithium citrate | Lithium citrate may increase the neurotoxic activities of Prothipendyl. |
| Lithium hydroxide | Lithium hydroxide may increase the neurotoxic activities of Prothipendyl. |
| Mequitazine | Prothipendyl may increase the arrhythmogenic activities of Mequitazine. |
| Tetrabenazine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Tetrabenazine. |
| Deutetrabenazine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Deutetrabenazine. |
| Ethanol | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Seproxetine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Prothipendyl. |
| Indalpine | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Alaproclate. |
| Amitriptyline | The risk or severity of adverse effects can be increased when Amitriptyline is combined with Prothipendyl. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Prothipendyl. |
| Imipramine | The risk or severity of adverse effects can be increased when Imipramine is combined with Prothipendyl. |
| Nortriptyline | The risk or severity of adverse effects can be increased when Nortriptyline is combined with Prothipendyl. |
| Amoxapine | The risk or severity of adverse effects can be increased when Amoxapine is combined with Prothipendyl. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Prothipendyl. |
| Maprotiline | The risk or severity of adverse effects can be increased when Maprotiline is combined with Prothipendyl. |
| Doxepin | The risk or severity of adverse effects can be increased when Doxepin is combined with Prothipendyl. |
| Desipramine | The risk or severity of adverse effects can be increased when Desipramine is combined with Prothipendyl. |
| Pizotifen | The risk or severity of CNS depression can be increased when Pizotifen is combined with Prothipendyl. |
| Dosulepin | The risk or severity of adverse effects can be increased when Dosulepin is combined with Prothipendyl. |
| Zopiclone | The risk or severity of adverse effects can be increased when Prothipendyl is combined with Zopiclone. |
| Eletriptan | The risk or severity of adverse effects can be increased when Eletriptan is combined with Prothipendyl. |
| Cabergoline | The risk or severity of adverse effects can be increased when Cabergoline is combined with Prothipendyl. |
| Zolmitriptan | The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Prothipendyl. |
| Dihydroergotamine | The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Prothipendyl. |
| Protriptyline | The risk or severity of adverse effects can be increased when Protriptyline is combined with Prothipendyl. |
| Meperidine | The risk or severity of adverse effects can be increased when Meperidine is combined with Prothipendyl. |
| Dextromethorphan | The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Prothipendyl. |
| Mazindol | The risk or severity of adverse effects can be increased when Mazindol is combined with Prothipendyl. |
| Linezolid | The risk or severity of adverse effects can be increased when Linezolid is combined with Prothipendyl. |
| Sumatriptan | The risk or severity of adverse effects can be increased when Sumatriptan is combined with Prothipendyl. |
| Ergotamine | The risk or severity of adverse effects can be increased when Ergotamine is combined with Prothipendyl. |
| Trimipramine | The risk or severity of adverse effects can be increased when Trimipramine is combined with Prothipendyl. |
| Tranylcypromine | The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Prothipendyl. |
| Phenelzine | The risk or severity of adverse effects can be increased when Phenelzine is combined with Prothipendyl. |
| Fentanyl | The risk or severity of adverse effects can be increased when Fentanyl is combined with Prothipendyl. |
| Almotriptan | The risk or severity of adverse effects can be increased when Almotriptan is combined with Prothipendyl. |
| Naratriptan | The risk or severity of adverse effects can be increased when Naratriptan is combined with Prothipendyl. |
| Rizatriptan | The risk or severity of adverse effects can be increased when Rizatriptan is combined with Prothipendyl. |
| Frovatriptan | The risk or severity of adverse effects can be increased when Frovatriptan is combined with Prothipendyl. |
| Selegiline | The risk or severity of adverse effects can be increased when Selegiline is combined with Prothipendyl. |
| Ergoloid mesylate | The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Prothipendyl. |
| Chlorpheniramine | The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Prothipendyl. |
| Procarbazine | The risk or severity of adverse effects can be increased when Procarbazine is combined with Prothipendyl. |
| Moclobemide | The risk or severity of adverse effects can be increased when Moclobemide is combined with Prothipendyl. |
| Bromocriptine | The risk or severity of adverse effects can be increased when Bromocriptine is combined with Prothipendyl. |
| Clomipramine | The risk or severity of adverse effects can be increased when Clomipramine is combined with Prothipendyl. |
| Isocarboxazid | The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Prothipendyl. |
| Ergometrine | The risk or severity of adverse effects can be increased when Ergometrine is combined with Prothipendyl. |
| Rasagiline | The risk or severity of adverse effects can be increased when Rasagiline is combined with Prothipendyl. |
| Lorcaserin | The risk or severity of adverse effects can be increased when Lorcaserin is combined with Prothipendyl. |
| Mianserin | The risk or severity of adverse effects can be increased when Mianserin is combined with Prothipendyl. |